UNSPSC 51283410: Sarpicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O70J1GE4YB, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta))-, methoxymethyl ester but generally known as sarpicillin, which bears US NIH Compound Identifier 65429.

UNSPSC 51283410 Sarpicillin is a Commodity code that nominally identifies a specific antibiotic pharmaceutical product, yet recent state and local procurement activity under this code shows no purchases of sarpicillin itself. Instead, the code has been tagged to solicitations for naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription fulfillment programs. State and local governments are using this code to procure a mix of emergency medical supplies, opioid-reversal agents, pharmacy benefit administration services, and general pharmaceutical inventory — a scope that extends well beyond the antibiotic product the code nominally describes. Issuing bodies include county health departments, state health and human services commissions, city fire departments, and cooperative purchasing alliances spanning multiple states. The mismatch between the code's name and actual purchasing activity suggests either broad code reuse within procurement systems or potential miscoding by issuing bodies.

Geographic activity spans Florida, Texas, Minnesota, and Oregon, with the most recent opportunities concentrated in the South and Midwest. Seminole County, Florida released an IFB (solicitation IFB60459723LAS, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually for the county's community health program. The City of Tampa issued an IFB for medical and first aid supplies (26P00145, due March 13, 2026, estimated contract value $700,000.00) exclusively for certified Small Local Business Enterprises under a sheltered market designation, with a 5 percent bid discount capped at $10,000. The Texas Health and Human Services Commission posted a Request for Information (HHS0017013, due April 3, 2026) to explore direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with awards effective July 1, 2026 and distribution through three authorized wholesalers serving multiple state and local agencies across Minnesota and Oregon.